1. Home
  2. ERII vs MYGN Comparison

ERII vs MYGN Comparison

Compare ERII & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Recovery Inc.

ERII

Energy Recovery Inc.

HOLD

Current Price

$6.72

Market Cap

400.7M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.82

Market Cap

372.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERII
MYGN
Founded
1992
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.7M
372.1M
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
ERII
MYGN
Price
$6.72
$5.82
Analyst Decision
Hold
Hold
Analyst Count
4
9
Target Price
★ $8.00
$4.11
AVG Volume (30 Days)
713.8K
★ 2.7M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.00
N/A
EPS
★ N/A
N/A
Revenue
$134,987,000.00
★ $771,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$44.10
$5.47
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 2.33
52 Week Low
$6.56
$2.74
52 Week High
$18.30
$8.50

Technical Indicators

Market Signals
Indicator
ERII
MYGN
Relative Strength Index (RSI) 38.52 74.13
Support Level N/A $5.57
Resistance Level $7.15 $6.34
Average True Range (ATR) 0.20 0.33
MACD 0.02 0.16
Stochastic Oscillator 19.33 92.25

Price Performance

Historical Comparison
ERII
MYGN

About ERII Energy Recovery Inc.

Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: